Bloomberg News

ResMed Promotes Mick Farrell to Replace Father as CEO

February 20, 2013

ResMed Inc. (RMD:US), a maker of machines to regulate breathing for people with sleep disorders, promoted Mick Farrell to replace his father as chief executive officer.

Farrell, 40, has served as president of the Americas since 2011, overseeing a division where sales rose more than 30 percent in the past seven quarters, the Poway, California-based company said in a statement today. His father, Peter Farrell, 70, will remain executive chairman through the end of the year, then serve as non-executive chairman.

Rob Douglas, the chief operating officer, will assume the role of president, the company said. ResMed generated more than half of its $1.4 billion in sales last fiscal year in the U.S.

“It was easily determined that members of the very talented and experienced team that have driven much of the company’s great success over the past decade would be the best suited to lead the company to its next stage of growth and development,” said Gary Pace, ResMed’s lead director and chairman of the board’s succession committee.

Before joining ResMed in 2001, Mick Farrell worked for Genzyme Corp., Dow Chemical Co., Arthur D. Little and BHP Billiton Ltd. He has a bachelor’s of engineering degree from the University of New South Wales and a master’s of science from the Massachusetts Institute of Technology.

To contact the reporter on this story: Michelle Fay Cortez in Minneapolis at mcortez@bloomberg.net

To contact the editor responsible for this story: Reg Gale at rgale5@bloomberg.net


Silicon Valley State of Mind
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

Companies Mentioned

  • RMD
    (ResMed Inc)
    • $52.07 USD
    • 0.54
    • 1.04%
Market data is delayed at least 15 minutes.
 
blog comments powered by Disqus